Breathe Well Live Well
|
KALBITOR (ecallantide) Data in HAE Presented at the American College of …
PharmaLive.com (press release) (NASDAQ: DYAX) announced today that two oral and two poster presentations featuring KALBITOR® (ecallantide) data in hereditary angioedema (HAE) were presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting held … KALBITOR(R) (ecallantide) Data in HAE Presented at the American College of … |
View full post on asthma – Google News
|
KALBITOR® (ecallantide) Data in HAE Presented at the American College of …
Business Wire (press release) (NASDAQ: DYAX) announced today that two oral and two poster presentations featuring KALBITOR ® (ecallantide) data in hereditary angioedema (HAE) were presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting held … KALBITOR(R) (ecallantide) Data in HAE Presented at the American College of … |
View full post on asthma – Google News
|
Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American …
MarketWatch (press release) 5, during the American College of Allergy, Asthma and Immunology annual meeting in Boston. "In addition to a reduced rate of serious bacterial infections, the phase III study data suggest potentially useful attributes of HyQ, such as the possibility … |
View full post on asthma – Google News
|
Teva Presents New Data on QNASL(TM) at the 2011 American College of Allergy …
MarketWatch (press release) In addition, the presence of co-morbidities such as asthma and sinusitis further increase AR-related treatment costs. QNASL(TM) is an investigational intranasal corticosteroid in development for the treatment of allergic rhinitis symptoms. … Teva Presents New Data On QNASL™ At The 2011 American College Of Allergy … |
View full post on asthma – Google News
|
Perrigo Company to Attend the 2011 Annual Meeting of the American College of …
istockAnalyst.com (press release) ALLEGAN, Mich., Oct. 28, 2011 /PRNewswire/ — Perrigo Company today announced that it will attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology Conference (ACAAI) Nov. 3-8 at the Hynes Convention Center and the … HollisterStier Allergy to Attend ACAAI 2011 Annual Scientific Meeting |
View full post on asthma – Google News
|
Perrigo Company to Attend the 2011 Annual Meeting of the American College of …
PR Newswire (press release) ALLEGAN, Mich., Oct. 28, 2011 /PRNewswire/ — Perrigo Company today announced that it will attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology Conference (ACAAI) Nov. 3-8 at the Hynes Convention Center and the … |
View full post on asthma – Google News
|
Brazilian fencer Tais Rochel dropped from Pan American Games team after …
Washington Post Brazilian officials say Rochel tested positive after using the asthma medicine Berotec just before the national fencing championships in September. Rochel says she “made a mistake” in an emergency during her trip to the championships. … |
View full post on asthma – Google News
|
Irene disease
Waterbury Republican American (blog) The Post's coverage is noteworthy for its reference to asthma, which we've all been trained to believe is caused by those nasty polluting power plants and industrial plants owned rich people. (Those who promote this viewpoint never seem to grasp that … Tropical Storm Irene leaves miserable allergy season in her wake |
View full post on asthma – Google News
|
Air Pollution in Dearborn-Detroit area linked to higher asthma rates
Arab American News But according to a new study, many of these residents have also grown familiar to the disease of Asthma, at a rate that's alarmingly higher than usual. The new study, which is a collaborative effort between Wayne State University, Michigan State, … |
View full post on asthma – Google News
|
Leukotrienes similarly effective to LABAs at treating asthma
Journal of the American Academy of Physician Assistants Clinical question What is the best initial or add-on therapy for asthma in the real world primary care setting? Bottom line This pragmatic trial found support for leukotriene inhibitors (LTIs) as initial therapy for asthma and as add-on therapy when an … |
View full post on asthma – Google News